| Dr Sapandeep Khurana, MD | |
|
6161 W Charleston Blvd, Las Vegas, NV 89146-1126 | |
| (702) 486-6091 | |
| Not Available |
| Full Name | Dr Sapandeep Khurana |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 21 Years |
| Location | 6161 W Charleston Blvd, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669649778 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | 14946 (Nevada) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stark Medicine Mckay Khurana Jeider Pllc | 1557601978 | 8 |
News Archive
Cyclacel Pharmaceuticals, Inc., today announced that it has opened enrollment of the SEAMLESS pivotal Phase 3 trial for the Company's sapacitabine oral capsules as a front-line treatment of elderly patients aged 70 years or older with newly diagnosed acute myeloid leukemia (AML) who are not candidates for intensive induction chemotherapy.
Prostate cancer survivors taking androgen deprivation therapy (ADT), a treatment commonly used to block the release of male hormones, are at a higher risk of developing chronic diseases, according to new research published this week.
Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria
The specialist National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust (SLaM) and Institute of Psychiatry (IoP) , King's College London (KCL) has been awarded nearly -1 million from the NIHR to support the development of the BRC's Case Register Interactive Search (CRIS) system.
Kumar Sharma, MD, FAHA, professor of medicine at the University of California, San Diego School of Medicine and director of the Center for Renal Translational Medicine, has received a $5.9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, to study kidney complications related to type 1 and type 2 diabetes.
› Verified 5 days ago
| Entity Name | State Of Nevada |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760572010 PECOS PAC ID: 9234022153 Enrollment ID: O20040212000160 |
News Archive
Cyclacel Pharmaceuticals, Inc., today announced that it has opened enrollment of the SEAMLESS pivotal Phase 3 trial for the Company's sapacitabine oral capsules as a front-line treatment of elderly patients aged 70 years or older with newly diagnosed acute myeloid leukemia (AML) who are not candidates for intensive induction chemotherapy.
Prostate cancer survivors taking androgen deprivation therapy (ADT), a treatment commonly used to block the release of male hormones, are at a higher risk of developing chronic diseases, according to new research published this week.
Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria
The specialist National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust (SLaM) and Institute of Psychiatry (IoP) , King's College London (KCL) has been awarded nearly -1 million from the NIHR to support the development of the BRC's Case Register Interactive Search (CRIS) system.
Kumar Sharma, MD, FAHA, professor of medicine at the University of California, San Diego School of Medicine and director of the Center for Renal Translational Medicine, has received a $5.9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, to study kidney complications related to type 1 and type 2 diabetes.
› Verified 5 days ago
| Entity Name | Humboldt General Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1750498010 PECOS PAC ID: 5193709798 Enrollment ID: O20061104000361 |
News Archive
Cyclacel Pharmaceuticals, Inc., today announced that it has opened enrollment of the SEAMLESS pivotal Phase 3 trial for the Company's sapacitabine oral capsules as a front-line treatment of elderly patients aged 70 years or older with newly diagnosed acute myeloid leukemia (AML) who are not candidates for intensive induction chemotherapy.
Prostate cancer survivors taking androgen deprivation therapy (ADT), a treatment commonly used to block the release of male hormones, are at a higher risk of developing chronic diseases, according to new research published this week.
Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria
The specialist National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust (SLaM) and Institute of Psychiatry (IoP) , King's College London (KCL) has been awarded nearly -1 million from the NIHR to support the development of the BRC's Case Register Interactive Search (CRIS) system.
Kumar Sharma, MD, FAHA, professor of medicine at the University of California, San Diego School of Medicine and director of the Center for Renal Translational Medicine, has received a $5.9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, to study kidney complications related to type 1 and type 2 diabetes.
› Verified 5 days ago
| Entity Name | Lisa A. Durette Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669679205 PECOS PAC ID: 6103927280 Enrollment ID: O20070719000161 |
News Archive
Cyclacel Pharmaceuticals, Inc., today announced that it has opened enrollment of the SEAMLESS pivotal Phase 3 trial for the Company's sapacitabine oral capsules as a front-line treatment of elderly patients aged 70 years or older with newly diagnosed acute myeloid leukemia (AML) who are not candidates for intensive induction chemotherapy.
Prostate cancer survivors taking androgen deprivation therapy (ADT), a treatment commonly used to block the release of male hormones, are at a higher risk of developing chronic diseases, according to new research published this week.
Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria
The specialist National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust (SLaM) and Institute of Psychiatry (IoP) , King's College London (KCL) has been awarded nearly -1 million from the NIHR to support the development of the BRC's Case Register Interactive Search (CRIS) system.
Kumar Sharma, MD, FAHA, professor of medicine at the University of California, San Diego School of Medicine and director of the Center for Renal Translational Medicine, has received a $5.9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, to study kidney complications related to type 1 and type 2 diabetes.
› Verified 5 days ago
| Entity Name | Stark Medicine Mckay Khurana Jeider Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053880856 PECOS PAC ID: 1557601978 Enrollment ID: O20190321002980 |
News Archive
Cyclacel Pharmaceuticals, Inc., today announced that it has opened enrollment of the SEAMLESS pivotal Phase 3 trial for the Company's sapacitabine oral capsules as a front-line treatment of elderly patients aged 70 years or older with newly diagnosed acute myeloid leukemia (AML) who are not candidates for intensive induction chemotherapy.
Prostate cancer survivors taking androgen deprivation therapy (ADT), a treatment commonly used to block the release of male hormones, are at a higher risk of developing chronic diseases, according to new research published this week.
Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria
The specialist National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust (SLaM) and Institute of Psychiatry (IoP) , King's College London (KCL) has been awarded nearly -1 million from the NIHR to support the development of the BRC's Case Register Interactive Search (CRIS) system.
Kumar Sharma, MD, FAHA, professor of medicine at the University of California, San Diego School of Medicine and director of the Center for Renal Translational Medicine, has received a $5.9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, to study kidney complications related to type 1 and type 2 diabetes.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sapandeep Khurana, MD 6161 W Charleston Blvd, Las Vegas, NV 89146-1126 Ph: () - | Dr Sapandeep Khurana, MD 6161 W Charleston Blvd, Las Vegas, NV 89146-1126 Ph: (702) 486-6091 |
News Archive
Cyclacel Pharmaceuticals, Inc., today announced that it has opened enrollment of the SEAMLESS pivotal Phase 3 trial for the Company's sapacitabine oral capsules as a front-line treatment of elderly patients aged 70 years or older with newly diagnosed acute myeloid leukemia (AML) who are not candidates for intensive induction chemotherapy.
Prostate cancer survivors taking androgen deprivation therapy (ADT), a treatment commonly used to block the release of male hormones, are at a higher risk of developing chronic diseases, according to new research published this week.
Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria
The specialist National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust (SLaM) and Institute of Psychiatry (IoP) , King's College London (KCL) has been awarded nearly -1 million from the NIHR to support the development of the BRC's Case Register Interactive Search (CRIS) system.
Kumar Sharma, MD, FAHA, professor of medicine at the University of California, San Diego School of Medicine and director of the Center for Renal Translational Medicine, has received a $5.9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, to study kidney complications related to type 1 and type 2 diabetes.
› Verified 5 days ago
Dr. Ejine Okoroafor, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 5440 W Sahara Ave, Suite 202, Las Vegas, NV 89146 Phone: 914-426-7774 | |
Dr. Garet Jefferson Zaugg, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2020 Wellness Way Ste 300, Las Vegas, NV 89106 Phone: 702-432-2233 Fax: 702-800-5456 | |
Dr. Muhammed A Hyder, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2465 E Twain Ave, Las Vegas, NV 89121 Phone: 702-789-6201 Fax: 304-522-0686 | |
Dr. Krista Linn Pinard, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3016 W Charleston Blvd Ste 150, Las Vegas, NV 89102 Phone: 702-790-2701 | |
Gobinder S. Chopra, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 6410 Medical Center St Ste A100, Las Vegas, NV 89148 Phone: 702-796-8500 Fax: 702-796-8502 | |
Eden Santiago Lee, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3014 W Charleston Blvd Ste 130, Las Vegas, NV 89102 Phone: 702-671-6475 Fax: 702-671-6440 | |
John Reitano, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 501 S Rancho Dr, Ste I62, Las Vegas, NV 89106 Phone: 702-897-7250 Fax: 702-706-4838 |